CMS announced it will begin coverage determination investigations for the controversial Alzheimer’s drug, Aduhelm, while the drug’s approval process is also being investigated by the FDA....
Happy Tuesday! Folks on either coast of the United States are facing either record high temperatures or levels of rainfall. As is the case most times, meteorologists are the only ones satisfied.
FDA...
While the pandemic shone a bright light on mental health, many Americans faced struggles accessing counseling services due to cost and other barriers. As Delta variant becomes the dominant strain of...
CMS proposed a value-based payment model for the treatment of end-stage renal disease and released a final ruling to combat surprise billing. Meanwhile, Congress introduced a bill to expand broadband...
Welcome back to work after a long (and for many in the Northeast rainy) weekend. Direct-to-consumer marketing appears to be paying off for pharma companies as far as Medicare drug spending is...
CMS issued two proposed bills that would expand home healthcare and access to health insurance exchanges. Meanwhile, Congress continues to push for telehealth bills that would increase rural access to...
United States officials have paused the distribution of Eli Lilly’s COVID-19 antibody therapy after it proves ineffective against variants. New research shows the ground ambulance rides are...
In perhaps a wake-up call to pharmaceutical companies, pharmacy benefit managers, and payers, data from GoodRx shows that its platform has generated $30 billion in savings for consumers to date. In...
The Supreme Court once again upholds the ACA, but experts are worried some may still challenge the law. Meanwhile, HHS funding aims to bolster the public health IT workforce and intra-agency...
Real-world data shows that Gilead’s remdesivir reduces the risk of mortality for COVID-19 patients. Precision medicine is set for advancement at Weill Cornell Medicine with the launch of a...
Good news: A Phase 3 study of Regeneron’s COVID-19 antibody cocktail shows that the therapy is effective in reducing the risk of death for patients suffering from the virus. The bad news:...
To improve access to COVID-19 testing and vaccination, FDA, CMS, and HHS are increasing vaccine supplies, vaccination sites, and funding. Meanwhile, HHS extended key reporting deadlines for the...
The approval by FDA of Biogen’s Alzheimer’s drug Aduhelm has led to the resignation of three committee members, citing disagreement with the department’s decision. The efficacy of the...
As payers prepare to comply with specific CMS interoperability deadlines, it is critical that they keep in mind the overarching goals of interoperability, not just the compliance details.
Listen to...
It’s been a busy week in healthcare, beginning with FDA’s approval of Biogen’s Alzheimer’s drug, Aduhelm, which continues to draw the ire of industry experts across the...
In an effort to reduce the US reliance on the global pharmaceutical supply chain, the Biden Administration accepted recommendations for improving the US supply chain. Meanwhile, the FDA approved a...
A heatwave has many across the country seeking shelter for a different reason. Stay cool out there!
FDA APPROVES BIOGEN’S ALZHEIMER’S DRUG AFTER DEBATE
The FDA has officially approved...
As the healthcare industry moves toward interoperability, payers are juggling numerous factors to both meet CMS requirements and further the aims of interoperability.
The industrywide movement toward...
As the DOJ sets its eyes on COVID-19-related telefraud, CMS called for public comments on delaying value-based drug payment rules. Meanwhile, a new Senate bill proposes expanding VA mental health...
Today’s healthcare headlines comes with our Memorial Day Weekend countdown. We’re almost there.
Congress OKs Brooks-LaSure as CMS Head
The Senate has confirmed Chiquita Brooks-LaSure to...
